A recent study found that the spliceosome, a dynamic macromolecular ribonucleoprotein (RNP) complex that catalyses the splicing of nuclear pre-mRNA into mRNA, is a therapeutic vulnerability in breast cancer models driven by MYC, due to MYC-induced elevation of mRNA synthesis [8]. The gene discussed is MYC; the disease is breast carcinoma.